Ophthalmology · Allentown, PA
NPI
1255443073
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1251 South Cedar Crest Blvd, Suite 307
Allentown, PA, 18103
Phone (610) 820-6320
Groups this clinician bills Medicare through
Medicare paid, 2024
$634K
4,732 services
Medicare patients, 2024
1,351
Average age 75
Drug cost, 2024
$576K
2,565 prescriptions
Company payments, 2025
$15K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A de Rose was code 66984 (cataract surgery), 1,267 times for 543 patients. In total David A de Rose billed 4,732 services in 45 codes, and Medicare paid $634K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 66984 Cataract Surgery | Facility | 1,267 | 543 | $262.69 | $333K |
| 92136 Ultrasound - Nonspecific | Office | 1,073 | 700 | $27.37 | $29K |
| 99204 Office E&M - New | Office | 440 | 440 | $103.80 | $46K |
| 99214 Office E&M - Established | Office | 408 | 399 | $83.97 | $34K |
| 66821 Cataract Surgery | Office | 306 | 223 | $242.62 | $74K |
| 99213 Office E&M - Established | Office | 257 | 222 | $60.68 | $16K |
| 92133 Computerized Ophthalmic Imaging | Office | 148 | 143 | $23.37 | $3,459 |
| 92020 Ophthalmological E&M | Office | 117 | 116 | $19.40 | $2,270 |
| 92014 Ophthalmological E&M | Office | 104 | 99 | $85.42 | $8,884 |
| 92134 Computerized Ophthalmic Imaging | Office | 90 | 90 | $25.35 | $2,281 |
| 66991 Cataract Surgery | Facility | 69 | 29 | $309.15 | $21K |
| 99203 Office E&M - New | Office | 65 | 65 | $64.69 | $4,205 |
| 92004 Ophthalmological E&M | Office | 47 | 47 | $97.66 | $4,590 |
| 92083 Vision, Hearing, and Speech Services | Office | 46 | 44 | $36.04 | $1,658 |
| 92250 Angiography | Office | 41 | 40 | $18.82 | $771 |
By year: 2022 $667K for 5,214 services; 2023 $732K for 5,314 services; 2024 $634K for 4,732 services.
Medicare prescription drug claims, 2024
In 2024, the drug David A de Rose prescribed most often to Medicare patients was Ketorolac Tromethamine, with 647 prescriptions and refills. In total David A de Rose wrote 2,565 Medicare prescriptions that cost $576K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketorolac Tromethamine Generic | 647 | 654 | 382 | $7,534 |
| Prednisolone Acetate Generic | 441 | 733 | 247 | $21K |
| Prolensa Bromfenac Sodium | 319 | 410 | 228 | $107K |
| Bromfenac Sodium Generic | 191 | 243 | 134 | $42K |
| Latanoprost Generic | 161 | 376 | 55 | $1,912 |
| Lumigan Bimatoprost | 115 | 224 | 36 | $57K |
| Ofloxacin Generic | 112 | 117 | 78 | $1,186 |
| Ilevro Nepafenac | 68 | 87 | 44 | $25K |
| Restasis Cyclosporine | 66 | 134 | 27 | $82K |
| Brimonidine Tartrate Generic | 59 | 95 | 34 | $5,206 |
| Timolol Maleate Generic | 50 | 105 | 19 | $2,395 |
| Cyclosporine Generic | 49 | 123 | 25 | $45K |
| Valacyclovir Valacyclovir Hcl | 35 | 84 | 15 | $1,885 |
| Travoprost Generic | 23 | 63 | Under 11 | $6,981 |
| Tobramycin Generic | 22 | 22 | 15 | $295 |
Brand drugs: 1,257 claims; generic drugs: 1,308 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A de Rose $15K ($15K in general payments such as food, travel and fees) from 10 companies. The largest payer was Alcon Vision LLC with $8,788.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 20 | $8,788 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $6,000 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $155 |
| Amgen Inc. AMGN | 1 | $118 |
| RxSight Inc RXST | 2 | $106 |
| Abbvie Inc. ABBV | 2 | $49.13 |
| Harrow Eye, LLC | 1 | $25.9 |
| Biotissue Holdings Inc. | 1 | $22.27 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $19.36 |
| Sight Sciences, Inc. SGHT | 1 | $14.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.